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Abstract
PepT1 is a member of the proton-oligopeptide cotransporter family SLC15, which mediates the transport of di/tripeptides
from intestinal lumen into epithelial cells. MicroRNAs (miRNAs), a small noncoding RNAs (21–23 nucleotides), post-
transcriptionally regulate gene expression by binding to the 39-untranslated regions (UTRs) of their target mRNAs. Although
the role of most miRNAs remains elusive, they have been implicated in vital cellular functions such as intestinal epithelial
cells differentiation, proliferation, and apoptosis. In the present study, we investigated the effect of intestinal epithelial
PepT1 expression on microRNA (miRNA) expression/secretion in the colons of control mice and in mice with experimentally
induced colonic inflammation (colitis). The colonic miRNA expression was deregulated in both colitis and control mice but
the deregulation of miRNA expression/secretion was specific to colonic tissue and did not affect other tissues such as spleen
and liver. Intestinal epithelial PepT1-dependent deregulation of colonic miRNA expression not only affects epithelial cells
but also other cell types, such as intestinal macrophages. Importantly, we found the miRNA 23b which was known to be
involved in inflammatory bowel disease was secreted and transported between cells to impose a gene-silencing effect on
recipient intestinal macrophages. Based on our data, we may conclude that the expression of a specific protein, PepT1, in
the intestine affects local miRNA expression/secretion in the colon on a tissue specific manner and may play an important
role during the induction and progression of colitis. Colonic miRNA expression/secretion, regulated by intestinal epithelial
PepT1, could play a crucial role in cell-to-cell communication during colitis.
Citation: Ayyadurai S, Charania MA, Xiao B, Viennois E, Zhang Y, et al. (2014) Colonic miRNA Expression/Secretion, Regulated by Intestinal Epithelial PepT1, Plays
an Important Role in Cell-to-Cell Communication during Colitis. PLoS ONE 9(2): e87614. doi:10.1371/journal.pone.0087614
Editor: Josep Bassaganya-Riera, Virginia Tech, United States of America
Received November 4, 2013; Accepted December 23, 2013; Published February 19, 2014
Copyright:  2014 Ayyadurai et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the department of veteran’s affairs (Didier Merlin). The funders had no role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: sayyadurai@gsu.edu
Introduction
PepT1 is a di/tripeptide transporter [1–3] highly expressed in
epithelial cells of the small intestine, and poorly expressed in the
colon [4,5]. However, colonic PepT1 expression is enhanced
under conditions of chronic inflammation such as Inflammatory
Bowel Disease (IBD) [4,6,7]. Recently, a polymorphism of the
hPepT1 gene has been shown to be associated with IBD
susceptibility, indicating a direct involvement of this transporter
in IBD [8]. Also, it has been shown that PepT1 expressed in
immune cells played an important role in promoting the immune
response during experimentally induced colitis compared to the
knock-out mice [9]. Recent study showed that IL-16 induces
intestinal inflammation by up regulating PepT1 expression in
puffer fish intestine and it subsequently transported the bacterial
peptide fMLP which triggers the intestinal inflammation [7].
To specifically examine the role played by hPepT1 in intestinal
epithelial cells (IECs) (including colonocytes) during intestinal
inflammation, we generated a transgenic mouse model, in which
hPepT1 was specifically expressed in IECs under the control of a
villin promoter (villin-hPepT1 mice). Western blotting confirmed
expression of hPepT1 in the colonocytes of transgenic mice (TG)
but not those of wild-type (WT) mice [10]. The mice appeared
healthy and exhibited normal body weight, breeding behavior,
and general appearance. The morphology of the gastrointestinal
tract as judged by histological examination appeared normal [10].
Immunohistochemical analysis verified hPepT1 membrane stain-
ing of colonocytes in villin-hPepT1 Tg mice, but not in WT mice
[10]. In addition, apical membrane vesicles prepared from
colonocytes of villin-hPepT1 mice, expressed significantly higher
levels of functional hPepT1 compared to WT mice [10]. Together,
the results clearly showed that villin-hPepT1 mice express hPepT1
in the colonic mucosa, which has also been observed in IBD
patients [4,6] and therefore represents an appropriate model in
which the pathogenic role of hPepT1 in IBD may be explored.
To assess the effect of hPepT1 expression in colonocytes during
inflammation, colitis was induced using dextran sulfate sodium
(DSS) and TNBS [10–14]. Such treatment induced a more drastic
weight loss in villin-hPepT1 mice with a higher clinical score
compared to WT mice [10]. The severity of DSS-induced colitis in
villin-hPepT1 mice was accompanied by a rise in inflammation, as
noted by colonoscopy, with massive mucosal erythema and
bleeding. DSS treatment increased the extent of histological
damage in villin-hPepT1 mice as shown by almost complete crypt
disruption and inflammatory infiltration throughout the mucosa
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and submucosa, consistent with the marked increase noted in
colonic MPO activity compared to that of WT mice. Importantly,
villin-hPepT1 animals also exhibited a marked increase in DSS-
induced colonic levels of the pro-inflammatory cytokines such as
IL-1b, IL-6, TNF-a and IFN-c, compared to WT animals [10].
Our studies demonstrated that IEC-specific hPepT1 expression
exacerbated the susceptibility of mice to DSS-induced colitis and
reduced intestinal recovery and healing after induction of
inflammation.
microRNA (miRNA), described in Caenorhabditis elegans in 1993
[15,16] are 18 to 22 nucleotides in length [17] and negatively
regulate target mRNAs by binding to their 39- untranslated region
(UTR) [18–20]. Each miRNA can target hundreds of mRNAs
within a given cell type [21] and a single mRNA is the target of
multiple miRNAs [22,23]. Thus, miRNAs contribute to the
regulation of over 30% of protein-coding genes [24]. MiRNAs
have been shown to play important roles in various biological
processes including immunity, cell proliferation and development
[25–27] and intestinal epithelial cell differentiation [28,29]. Many
studies have examined global miRNA expression in health and
disease conditions [17,30–35]. Tissue specific miRNAs from
mouse have already been investigated [36]. Recently, we have
shown the tissue specific expression of CD98 on miRNA
expression in the same tissue [37]. In the present study, we
investigated the effect of intestinal epithelial PepT1 expression on
miRNA expression in the colon of control mice and in mice
experiencing inflammation.
Materials and Methods
Generation of hPepT1 transgenic mice
Homozygous villin-hPepT1 mice were previously generated
[10] and FVB WT mice were used as controls. All animal
procedures were approved by the Animal Care Committee of
Emory University and Georgia State University and were
conducted in accordance to the Guide for the Care of Use of Laboratory
Animals from the US Public Health Service.
Induction of colitis
Six week old villin-hPepT1 and FVB WT male mice were used
for this study. Colitis was induced by the addition of 3% (w/v)
dextran sodium sulfate (DSS; molecular weight 36,000–50,000
Da; MP Biomedicals, LLC, OH) to the drinking water [9].
Physical characteristics such as body weight and pro and anti-
inflammatory cytokine profile were matched with previously
reported [10]. The mice were humanly euthanized, and colon,
spleen and liver tissue were processed further by extracting total
RNA for microarray analysis and immunohistochemistry after 7
days of DSS treatment.
RNA extraction and miRNA expression analysis by miRNA
Microarray
Total RNA containing miRNA was extracted from the liver,
spleen and colon of mice by RNeasy Plus Mini kit (Qiagen,
Valencia, CA) according to the manufacturer’s instruction given in
Qiagen supplementary protocol for purification of miRNA from
animal tissue. The yield and quality of RNA was verified. A size
fractionation step with YM-100 Microcon filter was done which
isolates nucleotides of ,200 bp or less (LC Sciences, Houston,
TX). MicroRNA microarrays were performed by using the
mParafloH microfluidic chip technology (LC Sciences). Probes for
the arrays were developed using version 16 of the miRBase
sequence database updated with 1145 miRNAs (http://www.
lcsciences.com/applications/transcriptomics/mirna-profiling/
mirna/). Data analysis for the arrays was performed using t-test,
ANOVA and/or clustering analysis. We compared transcripts of
FVB WT H2O vs villin-hPepT1 H2O, FVB WT H2O vs villin-
hPepT1 treated with DSS, FVB WT H2O vs FVB WT DSS-
treated and villin-hPepT1 H2O vs villin-hPepT1 DSS-treated
(Fig. 1).
Real-time RT-PCR analysis
cDNA was generated from the total RNAs isolated above using
the NCodeTM miRNA first-strand cDNA synthesis kit (Invitrogen,
Carlsbad, CA) or Maxima first strand cDNA synthesis kit (Thermo
Figure 1. Clustering graph of miRNAs.microRNA microarray results demonstrated that villin-hPepT1 and FVB WT mice treated with and without
DSS expressed different miRNA profiles. miRNAs expressed with a p value of ,0.01 and signal .500.
doi:10.1371/journal.pone.0087614.g001
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Scientific, Glen-Burnie, MD) as previously described [38]. Levels
of mature miRNAs expression were quantified by qRT-PCR using
MaximaH SYBR Green/ROX qPCR Master Mix (Thermo
Scientific, Pittsburgh, PA). The universal reverse primer provided
in the NCodeTM miRNA first-strand cDNA synthesis kit and the
specific microRNA forward primers were used. Small RNA 234 or
cel-mir-39 was used as housekeeping gene. Fold-induction was
calculated using the Ct method as follows: DDCt= (CtTar-
get2Cthousekeeping)group 12(CtTarget2Cthousekeeping)group 2, and the
final data were derived from 22DDCT. All primers used for qRT-
PCR are described in Table S5.
miRNA target prediction
To determine the potential target genes of detected miRNAs,
three different miRNA target prediction algorithms were used:
PicTar (http://pictar.mdc-berlin.de) [39], MicroCosm (http://
www.ebi.ac.uk/enright-srv/microcosm/htdocs/targets/v5/) [40]
and TargetScan (http://www.targetscan.org/) [41]. The Match-
miner program (http://discover.nci.nih.gov/matchmi ner/in-
dex.jsp) [42] was then used to determine genes that were identified
by at least two algorithms.
DAVID gene functional annotation tool
DAVID (the Database for Annotation, Visualization and
Integrated Discovery) is a bioinformatics resource developed by
the Laboratory of Immunopathogenesis and Bioinformatics [43].
All tools in the DAVID Bioinformatics Resources aim to provide
functional interpretation of large lists of genes derived from
genomic studies, such as microarray and proteomics studies.
DAVID can be found at http://david.niaid.nih.gov or http://
david.abcc.ncifcrf.gov. The DAVID Functional Annotation Tool
mainly provides typical batch annotation and gene-GO term
enrichment analysis to highlight the most relevant GO terms
associated with a given gene list. The p-values associated with each
annotation term inside each cluster are used to rank their
biological significance. Thus, the top ranked annotation groups
most likely have consistently lower p-values for their annotation
members.
The miRNAs predicted common protein targets from the
Matchminer program were later analyzed. The functional
annotation of each protein was analyzed through clusters formed
by DAVID. Each cluster that scored an enrichment score of .1.0
were taken for analysis and the p-value of each annotation cluster
verified.
Western blot analysis
Approximately 1.0 cm piece of colon were homogenized in
radioimmunoprecipitation assay buffer (RIPA) (150 mM NaCl,
0.5% sodium deoxycholate, 50 mM Tris-HCl, pH 8, 0.1% SDS,
0.1% Nonidet P-40) supplemented with protease inhibitors (Roche
Diagnostics, Indianapolis, IN) on ice. The homogenates were
centrifuged at 12,000 rpm for 10 min at 4uC. Total cell lysates
were resolved on 10% polyacrylamide gels (Bio-Rad, Hercules,
CA) and transferred to nitrocellulose membranes (Bio-Rad).
Membranes were then probed with Marcksl-1 (Proteintech,
10002-2-AP, Chicago, IL) and beta-tubulin (Sigma- Aldrich,
T8328, St Louis, MO). After washes, membranes were incubated
with appropriate horseradish peroxidase-conjugated secondary
antibody (GE Healthcare Biosciences, Pittsburgh, PA), and blots
were detected using the Enhanced Chemiluminescence Detection
kit (GE Healthcare Biosciences).
Immunohistochemistry
Paraffin-embedded tissue sections (5-mm) were deparaffinized in
xylene and rehydrated in an ethanol gradient. Epitope retrieval
was done by treating with 10 mM sodium citrate buffer (pH 6.0)
and 10 mM citric acid (4:1 ratio) at 120uC for 10 min in a pressure
cooker. Sections were blocked with 5% goat serum and then
incubated with Marcksl-1 (1:100 dilution) overnight at 4uC. After
washing with phosphate buffered saline (PBS), sections were
incubated with Alexa-Fluor 568 phalloidin (Invitrogen, 1:5000)
and horseradish peroxidase-conjugated secondary antibody for
45 minutes at room temperature in the dark. Sections were
mounted in mounting medium with 49, 6-diamidino-2-phenylin-
dole (DAPI) (Vector Laboratories, Burlingame, CA) and cover
slipped. Images were acquired using an Olympus microscope
equipped with an Hamamatsu Digital Camera ORCA-03G.
Secreted miRNA in colon culture
DSS treated villin-hpepT1 and FVB WT along with H2O
control mouse colons were cut and washed three times in sterile
PBS and cultured in RPMI media without serum at 37uC for
24 hrs. The supernatant was collected and centrifuged to sediment
the tissue particles. Cel-miR-39 was used as an invariant control
for the conditioned medium RNA extraction and qRT-PCR
analysis as described earlier [44,45]. 10 mL of 0.1 nM cel-miR-39
was added to each 1 mL aliquot of supernatant and vortexed for
30s. miRNAs extraction was performed using the Norgen Biotek
Exosome RNA extraction kit (Norgen Biotek, Ontario, Canada)
according to the manufacturer’s instructions and the RNA yield
was verified. miRNA profiles from the conditioned medium or
blank medium were assessed by qRT-PCR and further confirmed
by Signosis miRNA expression plate assay according to the
manufacturer’s protocol (Signosis Inc, Sunnyvale, CA) and
chemiluminescence was measured in a Biotek synergy 2.0
microplate reader (Biotek, Winooski, VT).
miRNA uptake experiment in macrophages
Although many miRNA’s up or down regulated in our study, it
has been reported that miRNA 23a and miRNA 23b have a
potential roles in ulcerative colitis and Crohn’s disease in patients
[46]. Therefore, we chose miRNA 23b for further study. MiRNA
23b uptake by macrophages was assessed using Cy3 labeled dsRNA
23b (59-Cy3 labeled antisense strand) (Integrated DNA Technolo-
gies, Coralville, IA). 36104 macrophage (RAW-264.7) cells were
grown in 6 chamber BD falcon culture slides (BD Bioscience,
Bedford, MA) at 37uC with 5% CO2 for 24 h. The Cy3 labeled
miRNA 23b at 50 nM concentration was added into the culture
medium and incubated at 37uC with 5% CO2 for 24 h. Cells were
washed with PBS and stained with Alexa Fluor 488 phalloidin
(Invitrogen) and vectashield mounting medium with DAPI (Vector
Laboratories, Burlingame, CA) and the slides were examined under
microscope for miRNA 23b uptake by macrophages.
Targeting Marcksl-1 39UTR by miRNA 23b in
macrophages
To examine whether miRNA-23b directly targets the 39UTR of
Marcksl-1 mRNA, Marcksl-1 39UTR was cloned downstream in
pEZX vector with neomycin/kanamycin selection with a lucifer-
ase reporter gene (Luc-Marcksl-1 39UTR) (Genecopoeia, Rock-
ville, MD). Precursor miRNA-23b cloned in CMV promoter with
ampicillin selection (Genecopoeia, Rockville, MD). The constructs
were transfected in XL gold ultracompetent cells (Agilent
Technologies, Santa Clara, CA) and selected with appropriate
antibiotic selection media. The plasmid extraction was done using
PepT1 Expression Alters Colonic miRNA Expression
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Qiagen Medi-plasmid extraction kit (Qiagen, Valencia, CA). The
plasmid concentration and the constructs position were verified
using restriction enzymes. RAW-264.7 cells were grown in 6 well
plate (3.36105) and Luc-Marcksl-1 39UTR construct was co-
transfected with miRNA-23b precursor. As controls, Luc-Marcksl-
1 39UTR and miRNA-23b precursor constructs alone transfected
in RAW 264.7 cells using Lipofectamine 2000 (Life Technologies,
Grand Island, NY) in Opti-MEM reduced serum medium
(GIBCO, Life Technologies, Grand Island, NY). Only RAW
264.7 cells used as negative control. After 4 h of transfection,
serum-free DMEM medium was added (cellgro, Manassas, VA).
Transfected cells were incubated at 37uC for 24 h with 5% CO2.
After incubation, the cells were washed with sterile PBS and
luciferase assay was carried out according to the manufactures
protocol (Genecopoeia, Rockville, MD). The targeting of miRNAs
Marcksl-1 39UTR was then assessed by measuring luciferase
activity in these cells.
Statistical analysis
Values were expressed as means 6 standard error of mean
(SEM). Statistical analysis was performed using unpaired two-tailed
t-test by GraphPad Prism 5 software. p,0.05 were considered
statistically significant.
Results
Differential effects of colonic PepT1 expression on
colonic miRNA synthesis
The expression of colonic miRNA transcripts was compared
between WT and villin-hPepT1 mice either treated with DSS, or
not, at the significance levels of p,0.01, p,0.05, and p,0.1 (Table
S1). Although large numbers of miRNAs were differentially
expressed, many yielded low signal strengths (,500). These
miRNAs and those for which the differential p-values greater than
0.01, were excluded from analysis (Fig. 1). Of the 15 miRNAs that
met our stringent criteria, 3 were discarded: the mature miRNAs,
mmu-miR-1937a, mmu-miR-1937b, and mmu-miR-1937c are in
fact fragments of tRNA (www.mirbase.org) (Fig. 2C). The
remaining 12 miRNAs with differential p-values,0.01 and of
signal strengths .500 were further analyzed by qRT-PCR to
determine fold changes (Fig. 2A and Fig. 2B). The data were
compared with the differential expression levels detected upon
Figure 2. Colonic miRNA expression levels are modulated in villin-hPepT1 and FVBWTmice with and without DSS.miRNAs expressed
with the a p-value of ,0.01 and signal .500 in microRNA microarray were analyzed by qRT-PCR (Fig. 2A). miRNA 3077, miRNA 1934, miRNA 2145
were not associated with any target mRNAs so these three miRNAs were excluded from further analysis (Fig. 2B) and the mature mmu-miR-1937a,
mmu-miR-1937b, and mmu-miR-1937c are fragments of tRNA (www.mirbase.org) so we eliminated these from further analyses (Fig. 2C). Difference in
miRNA expression noted as * p,0.05, ** p,0.001 and *** p,0.0001. Values represent means 6 SEM of n = 6/group.
doi:10.1371/journal.pone.0087614.g002
PepT1 Expression Alters Colonic miRNA Expression
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microarray analysis (Table S1). Out of 12 microRNAs, 10 were
differentially expressed, with statistical significance, when non-
treated WT and villin-hPepT1 mice were compared (the Student’s
t-test values were 0.001–0.04 with p-values,0.01; the fold changes
yielded upon qRT-PCR analysis were comparable).
Intestinal epithelial PepT1 expression upregulates basal
colonic miRNA expression
First, we investigated the effect of intestinal epithelial PepT1
expression on colonic (epithelial and non-epithelial cells) miRNA
expression in untreated mice. The expression levels of the 12
relevant miRNAs, as calculated by qRT-PCR, were in agreement
with the miRNA microarray data (Fig. 2A and 2B). A total of 10
colonic miRNAs (miRNA 132, 200b, 762, 199a-3p, 7b, 7c, 429,
23b, 23a, and 1934) were upregulated in villin-hPepT1 mice
compared to WT animals. In contrast, miRNAs 3077 and 2145
were expressed at similar levels in both mouse strains (Fig. 2B).
Importantly, we found that intestinal epithelial PepT1 overex-
pression did not affect the expression level of any of these 12
miRNAs in other tissues, including the liver and spleen. We herein
represented miRNA 132 (Fig. 3A), miRNA 200b (Fig. 3B) and
miRNA 23b (Fig. 3C) in liver and spleen respectively.
Thus, overexpression of intestinal epithelial PepT1 specifically
upregulated 10 colonic miRNAs. Next, we identified the mRNAs
targeted by these miRNAs using Pictar, MicroCosm and
Targetscan algorithms. Matchminer program was then employed
to identify target genes detected by at least two of the former
algorithms. miRNA 3077, miRNA 1934 and miRNA 2145 were
not found to target any mRNA and these three miRNAs were
excluded from further analysis (Fig. 2B). The remaining nine
miRNAs potentially regulated the expression of 704 genes (Table
S2).
DAVID functional annotation clustering of villin-hPepT1 and
WT at the basal level identified a total of 30 clusters of 453 genes;
161 genes were not part of any of these clusters. The most
enriched functional groups (score .1.0) included eleven clusters of
genes that were potentially downregulated. These genes are
involved in transcription regulation, protein biosynthesis, cell
division, endocytosis and calcium binding domains (Table 1) and
(Table S3).
Intestinal epithelial PepT1 expression deregulates colonic
miRNA expression under induced colitis
To investigate the effect of intestinal epithelial PepT1 expression
on colonic miRNA expression after induction of colitis, villin-
hPepT1 and WT mice were treated with DSS (given in drinking
Figure 3. hPepT1 regulates miRNA 132, miRNA 200b and miRNA 23b expression in colon- specific manner. Upon exposure to DSS or
normal drinking water, intestinal epithelial PepT1 overexpression did not affect the expression level of miRNA 132 (Fig. 3A), miRNA 200b (Fig. 3B) and
miRNA 23b (Fig. 3C) in liver or spleen. Values represent means 6 SEM of n = 6/group.
doi:10.1371/journal.pone.0087614.g003
PepT1 Expression Alters Colonic miRNA Expression
PLOS ONE | www.plosone.org 5 February 2014 | Volume 9 | Issue 2 | e87614
water) for 7 days and the levels of the nine colonic miRNAs
described above were measured. As shown in Fig. 2A, DSS did not
significantly affect the expression levels of colonic miRNAs
762,199a-3p, 429, 7b, or 7c in Tg mice, nor those of miRNAs
132, 200b, 7b, 7c, 429, or 23a in WT mice, compared to the levels
seen in untreated WT or Tg mice. In contrast, colonic miRNA
762 was up-regulated and colonic miRNA 199a-3p and miRNA
23b significantly down-regulated after DSS treatment in WT mice
Table 1. DAVID functional annotation clustering of villin-hPepT1 and FVB WT at the basal level.
Annotation
cluster
Enrichment
score Enriched functional group gene annotation/function Total gene count
1 4.77 Transcription and Transcription regulation 144
Nucleus 128
DNA – binding 54
2 3.31 Isopeptide bond 18
Ubl conjugation 27
Cross-links: glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO) 10
3 2.17 Nucleotide-binding 64
atp-binding 51
Transferase 53
Kinase 28
Domain: protein kinase 22
Binding site: ATP 24
Nucleotide phosphate-binding region: ATP 35
Serine/threonine-protein kinase 17
Active site: protein acceptor 24
4 2.05 Golgi apparatus 28
Topological domain: Lumenal 20
glycosyltransferase 11
Signal-anchor 17
5 2 Domain:W2 5
Initiation factor 4
Protein biosynthesis 5
6 1.83 Repeat: LDL-receptor class B1–20 71
Repeat: LDL-receptor class A1–8 27
Domain: EGF-like1–8 45
Domain: EGF-like 2;calcium binding 3
Endocytosis 6
Short sequence modif: Endocytosis signal 3
7 1.56 Nucleotide binding 6
P-Loop 6
GTP binding 4
8 1.37 Calcium and calcium binding region 1–2 41
Domain: EF-hand 1–3 24
9 1.35 Cell division 13
Cell cycle 19
Mitosis 8
10 1.12 Short sequence motif: DEAD box 4
Short sequence motif: Q box 4
Domain: Helicase C-terminal 6
Domain: Helicase ATP binding 6
Helicase 6
11 1.1 Domain: WW 1–3 9
The common proteins were clustered into 30 groups, but based on enrichment score .1.0. 11 groups were considered to be the potential targets with a total of 1100
genes.
doi:10.1371/journal.pone.0087614.t001
PepT1 Expression Alters Colonic miRNA Expression
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(Fig. 2A). Interestingly, colonic miRNAs 200b, 23b, and 23a were
down-regulated, and 132 up-regulated in villin-hPepT1 mice after
DSS-treatment (Fig. 2A). However, the expression levels of all nine
miRNAs were significantly higher in DSS-treated villin-hPepT1
compared to DSS treated WT mice (Fig. 2A). The miRNA fold
changes observed in microarray and verified by qRT-PCR are
listed in Table 2.
Upon DSS exposure, intestinal epithelial PepT1 overexpression
did not affect the level of miRNA expression in other tissues such
as liver or spleen (Fig. 3A, 3B and 3C). These results suggest that
the mRNAs targeted by the nine colonic miRNAs could be
differentially expressed in mice over expressing intestinal epithelial
PepT1 compared to animals in which intestinal epithelial PepT1 is
not expressed or expressed at low basal levels.
DAVID functional annotation clustering of villin-hPepT1 and
FVB WT upon DSS treatment identified a total of 15 clusters of
196 genes; 83 genes were not part of any of these clusters (Table
S4). The most enriched functional groups identified 4 clusters of
genes involved in transcription, ion channel and transport,
transcription, calcium binding and DNA binding (Table 3).
Deregulation of colonic miRNAs occurs not only in
epithelial cells but also in immune cells such as
macrophages
The miRNA expression analysis was performed with the whole
colon RNA, therefore the observed differences in colonic miRNA
expression likely reflect changes in both epithelial and non-
epithelial (i.e., immune) cells. For this purpose, we looked at the
mRNA and protein expression of a non-epithelial protein
macrophage myristoylated alanine-rich C kinase substrate
(Marcksl-1), a potential target gene of miRNA 23a and 23b
(Table S2). We chose miRNA 23b for our study as it was
previously shown to be involved in chronically active Crohn’s
disease [47], and active ulcerative colitis [46]. In addition,
Marcksl-1 is specifically expressed in macrophages [48] and has
been associated with gastrointestinal and inflammatory disease
[49], apoptosis and immune response [50,51]. As shown in Fig. 4A
and 4B, qRT-PCR and western blot analysis of Marcksl-1 mRNA
and protein levels upon DSS treatment were up-regulated in WT
mice compared to villin-hPepT1 and were in agreement with
colonic miRNA 23b expression levels after DSS treatment
(Fig. 2A). The anti-Marcksl-1 immunofluorescence from the colon
tissue of WT and villin-hPepT1 mice with and without DSS
treatment also showed the WT DSS-treated mice had higher
protein accumulation compared to DSS-treated villin-hPepT1
mice (Fig. 4C).
Intestinal epithelial PepT1 expression up-regulates the
secretion of colonic miRNA 23b
An analysis of miRNA 23b secretion was performed in colon
cultures from villin-hPepT1 and FVB WT mice with or without
DSS treatment. Secreted miRNA 23b in the colon culture
medium was assessed using a miRNA plate assay method and
qRT-PCR. The levels of secreted miRNA 23b were higher in
colonic tissues from villin-hPepT1 control mice compared to
colonic tissues from FVB WT mice (Fig. 5A and 5B). Notably,
DSS treatment significantly reduced the levels of secreted miRNA
23b in the colon culture medium coming from both WT and villin-
hPepT1 control mice (Fig. 5A and 5B). These results showed that
Table 2. miRNAs differentially expressed after DSS treatment
in colon.
Upregulated miRNAs Downregulated miRNAs
Name Fold change Name Fold change
mmu-miR-132 7.81 mmu-miR-200b 26.05
mmu let-7c 1.27 mmu-miR-429 21.71
mmu-miR-23b 22.85
mmu-miR-23a 21.92
miRNA microarray with the fold change (up-regulated and/or down-regulated)
listed in the table.
doi:10.1371/journal.pone.0087614.t002
Table 3. DAVID functional annotation clustering of villin-hPepT1 and FVB WT treated with DSS.
Annotation cluster Enrichment score Enriched functional group gene annotation/function Total gene count
1 2.96 Transcription and Transcription regulation 68
Nucleus 59
Activator 14
DNA – binding 26
2 1.92 Isopeptide bond 9
Ubl conjugation 13
Cross-links: glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO) 5
3 1.79 Calcium and calcium-binding region 1 and 2 26
Domin:EF-hand 1, 2 and 3 17
4 1.12 Potassium and Potassium transport 10
Potassium channel 4
Voltage-gated channel 5
Ion transport 9
Ionic channel 5
The common proteins obtained from the matchminer software were clustered in to 15 groups but based on enrichment score .1.0, a total of 4 groups were considered
to be the potential targets with a total of 270 genes.
doi:10.1371/journal.pone.0087614.t003
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an increase in intestinal epithelial PepT1 expression enhanced the
secretion of miRNA 23b from colonic tissue. Interestingly, up-
regulated levels of colonic miRNA 23b secretion induced by
intestinal epithelial hPepT1 expression remained higher in colonic
tissue expressing hPepT1 compared with colonic tissue with no or
low PepT1 expression (Fig. 5A and 5B).
Colonic miRNA 23b is actively up-taken by colonic
macrophages
Next, we investigated the possible uptake of secreted colonic
miRNA 23b by colonic macrophages. To examine this possibility,
we labeled the 59-end of dsmiRNA 23b with Cy3 and assessed its
uptake behavior into macrophages. As shown in Figure 5C, Cy3-
labeled miRNA 23b was effectively taken up by macrophages
incubated in the presence of 50 nM Cy3-labeled miRNA 23b for
24 hours at 37uC and pH 7.2. In addition, miRNA 23b uptake by
macrophages was inhibited at 4uC (Fig. 5D), indicating that it is an
active energy-dependent process. We also observed that miRNA
23b uptake by macrophages occurs at pH 7.0, 7.2 or 7.8 (Fig. 5E),
but not at pH 6.0 or 6.5 (Fig. 5F). This latter observation is
consistent with an endocytosis-mediated uptake mechanism.
Taken together, our results demonstrated that secreted colonic
miRNA 23b may be actively taken up by macrophages via an
endocytosis/phagocytosis-mediated mechanism.
MiRNA 23b directly targets the Marcksl-1 39UTR in
macrophages
To examine whether miRNA 23b directly targets the 39UTR of
Marcksl-1 mRNA, Marcksl-1 39UTR was cloned into a luciferase
reporter gene (Luc-Marcksl-1 39UTR), and this construct was
transfected into RAW 264.7 cells in the presence of miRNA 23b
precursor or alone. The targeting of miRNAs to Marcksl-1 39UTR
was then assessed by measuring luciferase activity in these cells. As
shown in Fig. 6, miRNA 23b co-transfected with Luc-Marcksl-1
39UTR significantly reduced luciferase activity in macrophage
cells after 24 h of transfection. In contrast, Luc-Marcksl-1 39UTR
luciferase activity remained unchanged. The reduction of lucifer-
ase activity indicated that miRNA 23b targeted Marcksl-1 in its
39UTR.
Discussion
It has been recently reported that specific human colonic
miRNAs are differentially expressed in IBD [30–32]. However,
the mechanism underlying this deregulation has not been studied.
To examine the effects of colonic PepT1 expression on colonic
miRNA expression in untreated mice and in mice with DSS-
induced colitis, we used a Tg mouse strain specifically overex-
pressing hPepT1, (villin-hPepT1) in colonic epithelial cells (IECs)
driven by the villin promoter [10]. Our results show that
Figure 4. Marcksl-1 is regulated by colonic miRNA 23b in DSS-treated FVB WT mice. Marcksl-1 mRNA fold level was quantified by qRT-PCR
(Fig. 4A). Western blot demonstrated protein expression was observed at high level in WT DSS-treated mice and at low level Marcksl-1 and/or not at
all in villin-hPepT1 DSS-treated mice compared to their respective control groups. Beta tubulin, 50 kDa was used as a loading control (Fig. 4B).
Immunofluorescence staining of Marcksl-1 protein expression (green) in FVB WT DSS mice compared to villin-hPepT1 DSS treated mice (Fig. 4C).
Marcksl-1 (FITC - green), nuclear staining (DAPI - blue) and F-actin staining (TRITC - red) and separate pictures were taken at 406 for each filter and
merged. Values represent means 6 SEM of n = 6/group. *p,0.05 and ***p,0.0001. Scale bar = 50 mm.
doi:10.1371/journal.pone.0087614.g004
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overexpression of PepT1 in IECs alters the profile of miRNA
expression in colonic cells, including both epithelial and non-
epithelial cells such as intestinal macrophages. In contrast, the
expression of miRNAs in non-colonic tissues was not affected in
villin-hPepT1 mice. This latter observation demonstrates that the
expression of intestinal epithelial PepT1 specifically deregulates
the expression of colonic miRNAs. Our results demonstrate that
expression of a specific protein involved in IBD (PepT1) may
Figure 5. Secretory miRNA in colon culture medium. miRNA 23b in conditioned medium was measured by miRNA plate assay
chemiluminescence method (Fig. 5A) and qRT-PCR (Fig. 5B). Cy3 labelled miRNA 23b uptake by macrophage (Fig. 5C). miRNA 23b uptake at 4uC
(Fig. 5D), miRNA 23b uptake at pH 7.0 (Fig. 5E) and pH 6.5 (Fig. 5F). F-actin (FITC - green), nuclear staining (DAPI - blue) and Cy3 labelled miRNA 23b
(TRITC -filter setting used) are stained and separate pictures were taken at 606 for each filter and merged respectively. Values represent means 6
SEM of n = 6/group. *p,0.05, **p,0.001 and ***p,0.0001. Scale bar = 10 mm.
doi:10.1371/journal.pone.0087614.g005
Figure 6. MiR-23b directly targets the Marcksl-1 39UTR in macrophages. Marcksl-1 39UTR was cloned into a luciferase reporter gene (Luc-
Marcksl-1 39UTR), and transfected into RAW 264.7 cells in the presence or absence of miRNA 23b precursor. The targeting of miRNAs to Marcksl-1
39UTR was then assessed by measuring luciferase activity in these cells. The miRNA 23b co-transfected with Luc-Marcksl-1 39UTR significantly reduced
luciferase activity in macrophage cells after 24 h of transfection. In contrast, Luc-Marcksl-1 39UTR had an increase of luciferase activity. Values
represent means 6 SEM of n = 3 and ***p,0.0001.
doi:10.1371/journal.pone.0087614.g006
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deregulate colonic miRNAs under conditions of both active (DSS)
and non-active (without DSS) inflammation. Interestingly, these
changes were initiated by intestinal epithelial PepT1 expression.
These data predict that in a disease state such as intestinal
inflammation, IECs over-expressing PepT1 can communicate
directly with IECs and/or indirectly through cell/cell interactions;
hence, epithelial PepT1 affects miRNA expression in other cells
that are in contact with IECs. For example, recent studies have
shown that extracellular vesicles contain functional mRNA,
miRNA, and DNA molecules that can be taken up by target
(acceptor) cells, indicating that these vesicles are a main
mechanism for cell-to-cell communication [52–56]. It has recently
been demonstrated by Kosaka et al. and other groups, that a
tumor-suppressive miRNA is secreted and transported between
cells to impose a gene-silencing effect on recipient cells [44,45,57].
miRNAs have been found in extracellular space such as plasma,
urine, saliva and constitute a form of cell-cell communication [58–
61]. Although we do not understand the cellular machinery
responsible for the secretion of miRNAs, it is known that they are
packaged into exosomes, microvesicles and apoptotic bodies by a
broad range of cell types [62–64]. Intriguingly, most extracellular
miRNAs are found outside of any lipid-containing vesicle. They
are rather associated with RNA-binding proteins (e.g., Argonaute 1
and 2), which may help protect them from the abundant nucleases
found in the extracellular space [65]. It has been previously shown
by others that under laboratory conditions colon tissues can be
cultured and shown to maintain viability [66–68]. Here, we
demonstrated that colonic tissue secretes miRNA 23b and this
secretion is regulated by the expression of intestinal epithelial
hPepT1. Interestingly, we have demonstrated that miRNA 23b is
actively taken up by macrophages, presumably through endocy-
tosis. In addition, we have demonstrated that miRNA 23b directly
targets the Marcksl-1 39UTR in macrophages. Our results suggest
that IECs may secrete miRNAs that are taken up by other cell
types such as macrophages, resulting in regulation of recipient cell
target genes such as Marcksl-1.
It has been previously shown that miRNA 23a and miRNA 23b
are involved in active ulcerative colitis [46] and chronically active
Crohn’s disease [32]. These results are consistent with the
observed colonic expression of miRNA 23a and 23b in WT and
villin-hPepT1 mice with or without DSS treatment (Fig. 2A).
Macrophage expression of Marcksl-1, one of the predicted target
genes of miRNA 23a and 23b (Table S2), has been suggested to
protect the intestine against inflammation [49]. Interestingly, we
have observed that, although Marcksl-1 is specifically expressed in
macrophages [48], its mRNA and protein expression profile are
altered during disease conditions in hPepT1 Tg mouse model. We
have indeed demonstrated that Marcksl-1 expression is increased
to a lesser extent in intestinal macrophages during DSS-induced
colitis in villin-hPepT1 mice than in WT mice. This observation
may suggest that Marcksl-1 expression in intestinal macrophages is
repressed by the more prominent elevation of miRNA 23b in
inflamed villin-hPepT1 mice compared with inflamed WT mice.
In addition, the low expression of Marcksl-1 in intestinal
macrophages in villin-hPepT1 mice under colitis conditions may
explain the greater degree of intestinal inflammation in these mice
that over-express PepT1 in IECs.
Herein, we have shown that miRNA 23b expression levels were
higher in the colonic tissues (but not other tissues) of villin-hPepT1
mice compared to WT mice, regardless of DSS treatment. Thus,
overexpression of intestinal epithelial PepT1 specifically up-
regulated colonic miRNA 23b in villin-hPepT1 mice. MiRNA-
23b expression was lower in DSS-treated villin-hPepT1 mice
compared to untreated villin-hPepT1 mice. However, miRNA
23b expression was higher in DSS-treated villin-hPepT1 mice
compared to DSS-treated WT mice. The latter observation
suggests that the level of miRNA 23b expression in DSS-treated
villin-hPepT1 mice (but not that in DSS-treated WT mice) could
be sufficient to target and repress Marcksl-1 expression, which is
lower in DSS-treated villin-hPepT1 mice than in DSS-treated WT
mice (Figure 4B and 4C). However, miRNA-23b over-expression
in untreated villin-hPepT1 mice does not appear to affect Marcksl-
1 expression, which is extremely low in non-inflamed intestine
(Figure 4C). Collectively, these results show that local expression of
a specific colonic protein may affect colonic miRNA expression/
secretion. In addition, colonic miRNA expression/secretion,
regulated by intestinal epithelial PepT1, may play an important
role in cell-to-cell communication during colitis. Together, these
results suggest that miRNA-23b expression may play a role in
regulating Marcksl-1 during intestinal inflammation.
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